The role of TNF receptor and TNF superfamily molecules in organ transplantation

被引:46
作者
Adams, AB
Larsen, CP
Pearson, TC
Newell, KA [1 ]
机构
[1] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA
关键词
allograft rejection; CD8(+) T cell; costimulation; TNF receptor;
D O I
10.1034/j.1600-6143.2002.020104.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The rapid increase in the number of molecules demonstrated to regulate immune responses has provided new opportunities for manipulation of the recipient immune response to transplanted organs. Molecules belonging to the TNF receptors and TNF superfamily are increasingly recognized as playing a major role in the regulation of immune responses to tumor, viral, and autoantigens. The mechanisms by which these molecules regulate immune responses are diverse. TNF receptor-related molecules have been shown to control the development of secondary lymphoid organs, affect the activation and survival of T cells and antigen presenting cells, and alter cytokine and chemokine production. An increasing amount of data suggest that some TNFR superfamily members are particularly important for the function of CD8(+) T cells. Based on our current understanding of these molecules it seems highly likely that strategies that target selected TNFR/ TNF superfamily molecules will be useful for controlling or preventing the rejection of transplanted organs and tissues.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 48 条
[1]   Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression [J].
Adams, AB ;
Durham, MM ;
Kean, L ;
Shirasugi, N ;
Ha, JW ;
Williams, MA ;
Rees, PA ;
Cheung, MC ;
Mittelstaedt, S ;
Bingaman, AW ;
Archer, DR ;
Pearson, TC ;
Waller, EK ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :1103-1111
[2]   FAS TRANSDUCES ACTIVATION SIGNALS IN NORMAL HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
MARASKOVSKY, E ;
TOUGH, TW ;
ROUX, E ;
SCHOOLEY, K ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2231-2235
[3]   Signaling through OX40 (CD134) breaks peripheral T-cell tolerance [J].
Bansal-Pakala, P ;
Jember, AGH ;
Croft, M .
NATURE MEDICINE, 2001, 7 (08) :907-912
[4]   Lymphotoxin-β-deficient mice show defective antiviral immunity [J].
Berger, DP ;
Naniche, D ;
Crowley, MT ;
Koni, PA ;
Flavell, RA ;
Oldstone, MBA .
VIROLOGY, 1999, 260 (01) :136-147
[5]   CD40 ligand (CD154) triggers a short-term CD4+ T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis [J].
Blair, PJ ;
Riley, JL ;
Harlan, DM ;
Abe, R ;
Tadaki, DK ;
Hoffmann, SC ;
White, L ;
Francomano, T ;
Perfetto, SJ ;
Kirk, AD ;
June, CH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :651-660
[6]  
Blotta MH, 1996, J IMMUNOL, V156, P3133
[7]   Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions [J].
Chen, AI ;
McAdam, AJ ;
Buhlmann, JE ;
Scott, S ;
Lupher, ML ;
Greenfield, EA ;
Baum, PR ;
Fanslow, WC ;
Calderhead, DM ;
Freeman, GJ ;
Sharpe, AH .
IMMUNITY, 1999, 11 (06) :689-698
[8]   Enhanced secretion of IFN-γ by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine [J].
Chen, NJ ;
Huang, MW ;
Hsieh, SL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :270-276
[9]   Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning [J].
Durham, MM ;
Bingaman, AW ;
Adams, AB ;
Ha, JW ;
Waitze, SY ;
Pearson, TC ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :1-4
[10]   Role of CD30+ T cells in rheumatoid arthritis:: a counterregulatory paradigm for Th1-driven diseases [J].
Gerli, R ;
Lunardi, C ;
Vinante, F ;
Bistoni, O ;
Pizzolo, G ;
Pitzalis, C .
TRENDS IN IMMUNOLOGY, 2001, 22 (02) :72-77